Comparison of Serum Vitamins C, D, and E in Iraqi Colorectal Cancer Patients with and without Non-Alcoholic Fatty Liver Disease to Healthy Individuals

Yasir H. Sabah; Firas Hassan

doi:10.59796/jcst.V14N3.2024.56

Authors

Yasir H. Sabah Department of Chemistry, College of Science, Al-Nahrain University, Iraq
Firas Hassan Department of Chemistry, College of science, Al-Nahrain University , Iraq

DOI:

https://doi.org/10.59796/jcst.V14N3.2024.56

Keywords:

Vitamin D, vitamin C, vitamin E, CRC, NAFLD

Abstract

Abstract

Depending on their protective properties against different cases of Colorectal Cancer (CRC), vitamins C, D, and E are the main focus of this research. CRC is one of the global public health concerns. 30 healthy individuals provided serum samples, whereas the group of CRC patients was divided into three, totaling 90 individuals. Group I consisted of 30 newly diagnosed cases of CRC. Group II 30 consisted of consisted of 30 CRC patients who were administered three cycles of chemotherapy. Group III consisted of 30 diagnosed CRC patients who also have non-alcoholic fatty liver disease (NAFLD). The concentrations and groups of vitamins C, D, and E were evaluated using ELISA. The levels of Vitamin C were significantly lower (p <0.0001) in individuals newly diagnosed with CRC, as compared to the control group. Patients who were recently diagnosed and treated for CRC and NAFLD exhibited comparable amounts of vitamin C. The level of vitamin E in control, newly diagnosed CRC and treated CRC patients displayed no significant differences, however comparing with newly diagnosed patients that suffered NAFLD, a significant decrease (p = 0.0014) in the level of vitamin E in CRC with NAFLD group was. The levels of Vitamin D in all groups of patients with colorectal cancer were significantly lower than those in the control group (p <0.0001). Colon cancer patients exhibited significantly decreased levels of vitamin C and D compared to healthy individuals. Vitamins showed potential as diagnostic markers for distinguishing between groups. It is necessary to analyze these findings as the level of serum vitamins may have potential use in the prognosis of the CRC in patients.

References

Abdulrahman, M. S., El-Yassin, H. D., & Al-Alwan, N. A. (2021). Serum vitamin Levels among Iraqi Cancer Patients Receiving Chemotherapy. Open Access Macedonian Journal of Medical Sciences, 9(B), 231-234. https://doi.org/10.3889/oamjms.2021.5469

Abraham, A., Kattoor, A. J., Saldeen, T., & Mehta, J. L. (2019). Vitamin E and its anticancer effects. Critical Reviews in Food Science and Nutrition, 59(17), 2831–2838. https://doi.org/10.1080/10408398.2018.1474169

Aggarwal, B. B., Gupta, S. C., Chaturvedi, M. M., & Reuter, S. (2010). Oxidative stress, inflammation, and cancer: how are they linked?. Free Radical Biology & Medicine, 49(11), 1603–1616. https://doi.org/10.1016/j.freeradbiomed.2010.09.006

Alzahrani, K. M., Fallatah, S. M., Almehmadi, R. A., Alghamdi, J. S., Alsulaimani, A. I., Alkhaldi, L. M., & Alsuwayhi, A. G. (2022). Colorectal Cancer and Its Screening Among Public in the Western Region of Saudi Arabia. Cureus, 14(7), Article e27404. https://doi.org/10.7759/cureus.27404

Baharuddin, N. S. B., Nasir, N. S. B., Mohamed Kamal, N. N. S. B. N., Saifuddin, S. N. B., & Mohamad, S. B. (2019). Vitamin E: An Antioxidant With Anticancer Properties?. Malaysian Journal of Medicine & Health Sciences, 15, 183-193.‏

Boughanem, H., Canudas, S., Hernandez-Alonso, P., Becerra-Tomás, N., Babio, N., Salas-Salvadó, J., & Macias-Gonzalez, M. (2021). Vitamin D Intake and the Risk of Colorectal Cancer: An Updated Meta-Analysis and Systematic Review of Case-Control and Prospective Cohort Studies. Cancers, 13(11), 2814. https://doi.org/10.3390/cancers13112814

Chen, J., Qin, F., Li, Y., Mo, S., Deng, K., Huang, Y., & Liang, W. (2020). High‐dose vitamin C tends to kill colorectal cancer with high MALAT1 expression. Journal of Oncology, 2020(1), Article 2621308. https://doi.org/10.1155/2020/2621308

Dong, Y., Liu, Y., Shu, Y., Chen, X., Hu, J., Zheng, R., ... & Guan, X. (2017). Link between risk of colorectal cancer and serum vitamin E levels: A meta-analysis of case-control studies. Medicine, 96(27), Article e7470. https://doi.org/10.1097/MD.0000000000007470

El Halabi, I., Bejjany, R., Nasr, R., Mukherji, D., Temraz, S., Nassar, F. J., ... & Shamseddine, A. (2018). Ascorbic Acid in Colon Cancer: From the Basic to the Clinical Applications. International Journal of Molecular Sciences, 19(9), Article 2752. https://doi.org/10.3390/ijms19092752.

Emmanouilidou, G., Kalopitas, G., Bakaloudi, D. R., Karanika, E., Theocharidou, E., Germanidis, G., & Chourdakis, M. (2022). Vitamin D as a chemopreventive agent in colorectal neoplasms. A systematic review and meta-analysis of randomized controlled trials. Pharmacology & Therapeutics, 237, Article 108252. https://doi.org/10.1016/j.pharmthera.2022.108252

Engelsen, O. (2010). The relationship between ultraviolet radiation exposure and vitamin D status. Nutrients, 2(5), 482–495. https://doi.org/10.3390/nu2050482

Fukui, A., Kawabe, N., Hashimoto, S., Murao, M., Nakano, T., Shimazaki, H., ... & Yoshioka, K. (2015). Vitamin E reduces liver stiffness in nonalcoholic fatty liver disease. World Journal of Hepatology, 7(27), 2749. https://doi.org/10.4254/wjh.v7.i27.2749

Husain, K., Centeno, B. A., Coppola, D., Trevino, J., Sebti, S. M., Malafa, M. P. (2017). δ-Tocotrienol, a natural form of vitamin E, inhibits pancreatic cancer stem-like cells and prevents pancreatic cancer metastasis. Oncotarget, 8(19), 31554-31567. https://doi.org/10.18632/oncotarget.15767.

Javed, M., Althwanay, A., Ahsan, F., Oliveri, F., Goud, H. K., Mehkari, Z., ... & Rutkofsky, I. H. (2020). Role of Vitamin D in Colorectal Cancer: A Holistic Approach and Review of the Clinical Utility. Cureus, 12(9), Article e10734. https://doi.org/10.7759/cureus.10734

Jiang, Q. (2014). Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy. Free Radical Biology & Medicine, 72, 76–90. https://doi.org/10.1016/j.freeradbiomed.2014.03.035

Ketkomol, P., Songsak, T., Jongrungruangchok, S., Madaka, F., & Pradubyat, N. (2024). The effect of 1'-acetoxychavicol acetate on A549 human non-small cell lung cancer. Journal of Current Science and Technology, 14(2), Article 43. https://doi.org/10.59796/jcst.V14N2.2024.43

Khalil, K. H., Al-Hassawi, B., & Abdo, J. (2021). Correlation of Neuroendocrine Differentiation with Neuroendocrine Cell Hyperplasia and Vascular Endothelial Growth Factor in Colorectal Adenocarcinoma. Baghdad Science Journal, 18(1), 0018-0018. https://doi:10.21123/bsj.2021.18.1.0018

Koenig, A., Younossi, Z., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016). Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology, 64(1), 73–84. https://doi.org/10.1002/hep.28431

Leenders, M., Leufkens, A. M., Siersema, P. D., Van Duijnhoven, F. J., Vrieling, A., Hulshof, P. J., ... & Bueno‐de‐Mesquita, H. B. (2014). Plasma and dietary carotenoids and vitamins A, C and E and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and Nutrition. International Journal of Cancer, 135(12), 2930–2939. https://doi.org/10.1002/ijc.28938

Linowiecka, K., Foksinski, M., & Brożyna, A. A. (2020). Vitamin C Transporters and Their Implications in Carcinogenesis. Nutrients, 12(12), Article 3869. https://doi.org/10.3390/nu12123869

Liu, C., Liu, T., Zhang, Q., Song, M., Zhang, Q., Shi, J., Deng, L., Chen, Y., Zheng, X., Lin, S., Wang, Z., Xie, H., Chen, S., Wu, S., Shi, H. (2024). Temporal relationship between inflammation and metabolic disorders and their impact on cancer risk. Journal of Global Health, 14, Article 04041. https://doi.org/10.7189/jogh.14.04041.

Marques, H. S., de Brito, B. B., da Silva, F. A. F., Santos, M. L. C., de Souza, J. C. B., Correia, T. M. L., ... & de Melo, F. F. (2021). Relationship between Th17 immune response and cancer. World Journal of Clinical Oncology, 12(10), 845-867. https://doi.org/10.5306/wjco.v12.i10.845

Meeker, S., Seamons, A., Maggio-Price, L., & Paik, J. (2016). Protective links between vitamin D, inflammatory bowel disease and colon cancer. World Journal of Gastroenterology, 22(3), 933–948. https://doi.org/10.3748/wjg.v22.i3.933

Meganathan, P., & Fu, J. Y. (2016). Biological Properties of Tocotrienols: Evidence in Human Studies. International Journal of Molecular Sciences, 17(11), Article 1682. https://doi.org/10.3390/ijms17111682

Mhaidat, N. M., Alzoubi, K. H., Kubas, M. A., Banihani, M. N., Hamdan, N., & Al-Jaberi, T. M. (2021). High levels of leptin and non-high molecular weight-adiponectin in patients with colorectal cancer: Association with chemotherapy and common genetic polymorphisms. Biomedical Reports, 14(1), Article 13. https://doi.org/10.3892/br.2020.1389

Muhidin, S. O., Magan, A. A., Osman, K. A., Syed, S., & Ahmed, M. H. (2012). The relationship between nonalcoholic fatty liver disease and colorectal cancer: the future challenges and outcomes of the metabolic syndrome. Journal of Obesity, 2012(1), Article 637538. https://doi.org/10.1155/2012/637538

Mustafa, A. J., Balaky, H. M., & Ismail, P. A. (2022). The role of Adipocytokines, Vitamin D, and C in Colorectal Cancer. Baghdad Science Journal, 20(3), 0690-0690.‏ https://doi.org/10.21123/bsj.2022.7245

Myara, I., Alamowitch, C., Michel, O., Heudes, D., Bariety, J., Guy-Grand, B., & Chevalier, J. (2003). Lipoprotein oxidation and plasma vitamin E in nondiabetic normotensive obese patients. Obesity Research, 11(1), 112–120. https://doi.org/10.1038/oby.2003.19

Najeeb, H. A., Othman, R., Salih, S. F., Mohammed, A. A., & Al Ismaeel, Q. (2020). Vitamin D level and endogenous DNA damage in patients with cancers in Duhok city, KRG-Iraq. Annals of Medicine and Surgery, 60, 462-467. https://doi.org/10.1016/j.amsu.2020.10.065

Niki, E. (2015). Evidence for beneficial effects of vitamin E. The Korean Journal of Internal Medicine, 30(5), 571–579. https://doi.org/10.3904/kjim.2015.30.5.571

Oh, J. H., Jun, D. W. (2023). The latest global burden of liver cancer: A past and present threat. Clinical and Molecular Hepatology, 29(2), 355-357. https://doi.org/10.3350/cmh.2023.0070

Panpraneecharoen, S., & Chumanee, S. (2022). Comparison of Tocopherol Contents in 13 Cold-Pressed Vegetable Oils Extracted from the Mini Screw Press Model T3 by RP-HPLC/FLD. Science & Technology Asia, 27(3), 27–36. Retrieved from https://ph02.tci-thaijo.org/index.php/SciTechAsia/article/view/241429

Pateiro, M., Munekata, P. E. S., Tsatsanis, C., Domínguez, R., Zhang, W., Barba, F. J., & Lorenzo, J. M. (2020). Evaluation of the protein and bioactive compound bioaccessibility/bioavailability and cytotoxicity of the extracts obtained from aquaculture and fisheries by-products. Advances in Food and Nutrition Research, 92, 97–125. https://doi.org/10.1016/bs.afnr.2019.12.002

Pires, A. S., Marques, C. R., Encarnação, J. C., Abrantes, A. M., Marques, I. A., Laranjo, M., ... & Botelho, M. F. (2018). Ascorbic Acid Chemosensitizes Colorectal Cancer Cells and Synergistically Inhibits Tumor Growth. Frontiers in Physiology, 9, Article 911. https://doi.org/10.3389/fphys.2018.00911

Rastogi, A., & Kapil, U. (2020). Magnitude of Non-alcoholic Fatty Liver Disease in South East Asia Region. Journal of Health Science and Alternative Medicine, 2(1), 1–11. Retrieved from https://he01.tci-thaijo.org/index.php/jhealthscialternmed/article/view/241249

Reiter, R. J., Sharma, R., Qiang, M., Rosales-Corral, S. & Manucha, W. (2020). Circadian and non-circadian melatonin: influences on glucose metabolism in cancer cells. Journal of Current Science and Technology, 10(1), 85–98. https://doi.org/10.14456/jcst.2020.9

Roa, F. J., Peña, E., Gatica, M., Escobar-Acuña, K., Saavedra, P., Maldonado, M., ... & Muñoz-Montesino, C. (2020). Therapeutic use of vitamin C in cancer: physiological considerations. Frontiers in Pharmacology, 11, Article 516113. https://doi.org/10.3389/fphar.2020.00211

Sadeq, E. J., & Mahdi, A. A. (2021). The correlation between Vitamin D and Colorectal Cancer in admitted patients in Oncology teaching hospital. Iraq Medical Journal, 5(4). https://doi.org/10.22317/imj.v5i4.1136

Saelee, P., Pongtheerat, T., Sophonnithiprasert, T., & Jinda, W. (2022). Clinicopathological significance of FANCAmRNA expression in Thai patients with breast cancer. Journal of Current Science and Technology, 12(3), 408-416. https://doi.org/10.14456/jcst.2022.31

Samant, G. V., & Sylvester, P. W. (2006). gamma-Tocotrienol inhibits ErbB3-dependent PI3K/Akt mitogenic signalling in neoplastic mammary epithelial cells. Cell Proliferation, 39(6), 563–574. https://doi.org/10.1111/j.1365-2184.2006.00412.x

Sato, K., Gosho, M., Yamamoto, T., Kobayashi, Y., Ishii, N., Ohashi, T., ... & Yoneda, M. (2015). Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials. Nutrition, 31(7-8), 923-930. https://doi.org/10.1016/j.nut.2014.11.018

Saygili, E. I., Konukoglu, D., Papila, C., & Akcay, T. (2003). Levels of plasma vitamin E, vitamin C, TBARS, and cholesterol in male patients with colorectal tumors. Biochemistry (Moscow), 68, 325-328. https://doi.org/10.1023/a:1023010418230

Shi, S., Wang, K., Ugai, T., Giannakis, M., Cazaubiel, J., Chan, A. T., ... & Song, M. (2023). Vitamin C intake and colorectal cancer survival according to KRAS and BRAF mutation: a prospective study in two US cohorts. British Journal of Cancer, 129(11), 1793–1800. https://doi.org/10.1038/s41416-023-02452-2

Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660

Temraz, S., Jabbour, J., Nassar, F., El Helou, R., Hadla, R., Mezher, M., ... & Shamseddine, A. (2023). Can plasma vitamin C predict survival in stage IV colorectal cancer patients? Results of a prospective cohort study. Frontiers in Nutrition, 10, Article 1110405. https://doi.org/10.3389/fnut.2023.1110405

Viola, V., Pilolli, F., Piroddi, M., Pierpaoli, E., Orlando, F., Provinciali, M., ... & Galli, F. (2012). Why tocotrienols work better: insights into the in vitro anti-cancer mechanism of vitamin E. Genes & Nutrition, 7(1), 29–41. https://doi.org/10.1007/s12263-011-0219-9

Vissers, M. C. M., & Das, A. B. (2018). Potential Mechanisms of Action for Vitamin C in Cancer: Reviewing the Evidence. Frontiers in Physiology, 9, Article 809. https://doi.org/10.3389/fphys.2018.00809

Wacker, M., & Holick, M. F. (2013). Vitamin D - effects on skeletal and extraskeletal health and the need for supplementation. Nutrients, 5(1), 111–148. https://doi.org/10.3390/nu5010111

Wang, P., Qin, X., Liu, M., & Wang, X. (2018). The burgeoning role of cytochrome P450-mediated vitamin D metabolites against colorectal cancer. Pharmacological Research, 133, 9-20. https://doi.org/10.1016/j.phrs.2018.04.022

White, R., Nonis, M., Pearson, J. F., Burgess, E., Morrin, H. R., Pullar, J. M., ... & Dachs, G. U. (2020). Low Vitamin C Status in Patients with Cancer Is Associated with Patient and Tumor Characteristics. Nutrients, 12(8), Article 2338. https://doi.org/10.3390/nu12082338

Xu, X., Yu, E., Liu, L., Zhang, W., Wei, X., Gao, X., ... & Fu, C. (2013). Dietary intake of vitamins A, C, and E and the risk of colorectal adenoma: a meta-analysis of observational studies. European Journal of Cancer Prevention, 22(6), 529-539. https://doi.org/10.1097/CEJ.0b013e328364f1eb

Younossi, Z. M., Golabi, P., de Avila, L., Paik, J. M., Srishord, M., Fukui, N., ... & Nader, F. (2019a). The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis. Journal of Hepatology, 71(4), 793–801. https://doi.org/10.1016/j.jhep.2019.06.021

Younossi, Z., Tacke, F., Arrese, M., Chander Sharma, B., Mostafa, I., Bugianesi, E., ... & Vos, M. B. (2019b). Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Hepatology, 69(6), 2672–2682. https://doi.org/10.1002/hep.30251